Presence of granulomas in mesenteric lymph nodes is associated with postoperative recurrence in Crohn's disease

Inflammatory Bowel Diseases

Volumn 21, Issue 11, 2015, Pages 2613-2618

  Li, Yi ^a   Stocchi, Luca ^a   Liu, Xiuli ^a   Rui, Yuanyi ^a   Liu, Ganglei ^a   Remzi, Feza H ^a   Shen, Bo ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Crohn's disease; granulomas; ileocolonic resection; mesenteric lymph nodes; postoperative recurrence

Indexed keywords

BIOLOGICAL PRODUCT; IMMUNOMODULATING AGENT; IMMUNOSUPPRESSIVE AGENT; MESALAZINE; PRESCRIPTION DRUG; TUMOR NECROSIS FACTOR INHIBITOR;

ADULT; ARTICLE; BIOLOGICAL THERAPY; CANCER PATIENT; CLINICAL FEATURE; COLONOSCOPY; CROHN DISEASE; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; FEMALE; GRANULOMA; HISTOPATHOLOGY; HUMAN; ILEOCOLONIC RESECTION; IMMUNOSUPPRESSIVE TREATMENT; INDEPENDENT VARIABLE; INTESTINE SURGERY; INTESTINE TUMOR; INTESTINE WALL GRANULOMA; LYMPHATIC SYSTEM TUMOR; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MESENTERY LYMPH NODE GRANULOMA; MESENTERY TUMOR; PATHOLOGIST; POSTOPERATIVE PERIOD; PREDICTIVE VALUE; PRESCRIPTION; PRIORITY JOURNAL; RECURRENCE RISK; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; ADOLESCENT; COLON; COLON RESECTION; COMPLICATION; FOLLOW UP; ILEUM; INTESTINE; KAPLAN MEIER METHOD; LYMPH NODE; MULTIVARIATE ANALYSIS; PATHOLOGY; PROCEDURES; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RECURRENT DISEASE; YOUNG ADULT;

ADOLESCENT; ADULT; COLECTOMY; COLON; CROHN DISEASE; FEMALE; FOLLOW-UP STUDIES; GRANULOMA; HUMANS; ILEUM; INTESTINES; KAPLAN-MEIER ESTIMATE; LYMPH NODES; MALE; MULTIVARIATE ANALYSIS; POSTOPERATIVE PERIOD; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RECURRENCE; RISK FACTORS; YOUNG ADULT;

EID: 84945248947     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/MIB.0000000000000541     Document Type: Article

References (62)

1. Farmer RG, Whelan G, Fazio VW. Long-Derm follow-up of patients with Crohn's disease. Relationship between the clinical pattern and prognosis. Gastroenterology. 1985;88:1818-1825.
2. Bernell O, Lapidus A, Hellers G. Risk factors for surgery and recurrence in 907 patients with primary ileocaecal Crohn's disease. Br J Surg. 2000; 87:1697-1701.
3. Cosnes J, Cattan S, Blain A, et al. Long-Derm evolution of disease behavior of Crohn's disease. Inflamm Bowel Dis. 2002;8:244-250.
4. Orlando A, Mocciaro F, Renna S, et al. Early post-operative endoscopic recurrence in Crohn's disease patients: data from an Italian Group for the study of inflammatory bowel disease (IG-IBD) study on a large prospective multicenter cohort. J Crohns Colitis. 2014;8:1217-1221.
5. Sorrentino D. State-of-Dhe-Art medical prevention of postoperative recurrence of Crohn's disease. Nat Rev Gastroenterol Hepatol. 2013;10: 413-422.
6. De Cruz P, Kamm MA, Prideaux L, et al. Postoperative recurrent luminal Crohn's disease: a systematic review. Inflamm Bowel Dis. 2012;18: 758-777.
7. Vuitton L, Koch S, Peyrin-Biroulet L. Preventing postoperative recurrence in Crohn's disease: what does the future hold? Drugs. 2013;73: 1749-1759.
8. Ahmed T, Rieder F, Fiocchi C, et al. Pathogenesis of postoperative recurrence in Crohn's disease. Gut. 2011;60:553-562.
9. D'Haens GR, Rutgeerts PJ. Postoperative recurrence of Crohn's disease: pathogenesis and prevention. Acta Gastroenterol Belg. 1994;57: 311-313.
10. D'Haens G, Rutgeerts P. Postoperative recurrence of Crohn's disease: pathophysiology and prevention. Inflamm Bowel Dis. 1999;5:295-303.
11. Moss AC. Prevention of postoperative recurrence of Crohn's disease: what does the evidence support? Inflamm Bowel Dis. 2013;19:856-859.
12. Yamamoto T, Shiraki M. Therapeutic strategies for prevention of postoperative recurrence in patients with Crohn's disease. Colorectal Dis. 2012;14:1555-1556; author reply 1556-1557.
13. van Loo ES, Dijkstra G, Ploeg RJ, et al. Prevention of postoperative recurrence of Crohn's disease. J Crohns Colitis. 2012;6:637-646.
14. Beaugerie L, Seksik P, Nion-Larmurier I, et al. Predictors of Crohn's disease. Gastroenterology. 2006;130:650-656.
15. Yamamoto T. Factors affecting recurrence after surgery for Crohn's disease. World J Gastroenterol. 2005;11:3971-3979.
16. Cottone M, Rosselli M, Orlando A, et al. Smoking habits and recurrence in Crohn's disease. Gastroenterology. 1994;106:643-648.
17. Ng SC, Lied GA, Arebi N, et al. Clinical and surgical recurrence of Crohn's disease after ileocolonic resection in a specialist unit. Eur J Gastroenterol Hepatol. 2009;21:551-557.
18. Alvarez-Lobos M, Arostegui JI, Sans M, et al. Crohn's disease patients carrying Nod2/CARD15 gene variants have an increased and early need for first surgery due to stricturing disease and higher rate of surgical recurrence. Ann Surg. 2005;242:693-700.
19. Simillis C, Yamamoto T, Reese GE, et al. A meta-Analysis comparing incidence of recurrence and indication for reoperation after surgery for perforating versus nonperforating Crohn's disease. Am J Gastroenterol. 2008;103:196-205.
20. D'Haens GR, Gasparaitis AE, Hanauer SB. Duration of recurrent ileitis after ileocolonic resection correlates with presurgical extent of Crohn's disease. Gut. 1995;36:715-717.
21. Raab Y, Bergstrom R, Ejerblad S, et al. Factors influencing recurrence in Crohn's disease. An analysis of a consecutive series of 353 patients treated with primary surgery. Dis Colon Rectum. 1996;39:918-925.
22. De Dombal FT, Burton I, Goligher JC. Recurrence of Crohn's disease after primary excisional surgery. Gut. 1971;12:519-527.
23. Unkart JT, Anderson L, Li E, et al. Risk factors for surgical recurrence after ileocolic resection of Crohn's disease. Dis Colon Rectum. 2008;51: 1211-1216.
24. Shepherd NA. Granulomas in the diagnosis of intestinal Crohn's disease: a myth exploded? Histopathology. 2002;41:166-168.
25. Jess T, Riis L, Vind I, et al. Changes in clinical characteristics, course, and prognosis of inflammatory bowel disease during the last 5 decades: a population-based study from Copenhagen, Denmark. Inflamm Bowel Dis. 2007;13:481-489.
26. Turner K, Genta RM, Lujan G, et al. Significance of the epithelioid granuloma in biopsies of Crohn's colitis. Inflamm Bowel Dis. 2014;20: 2271-2275.
27. Molnar T, Tiszlavicz L, Gyulai C, et al. Clinical significance of granuloma in Crohn's disease. World J Gastroenterol. 2005;11:3118-3121.
28. Ramzan NN, Leighton JA, Heigh RI, et al. Clinical significance of granuloma in Crohn's disease. Inflamm Bowel Dis. 2002;8:168-173.
29. Simillis C, Jacovides M, Reese GE, et al. Meta-Analysis of the role of granulomas in the recurrence of Crohn disease. Dis Colon Rectum. 2010; 53:177-185.
30. Matsumoto T, Nakamura S, Jin-No Y, et al. Role of granuloma in the immunopathogenesis of Crohn's disease. Digestion. 2001;63(suppl 1):43-47.
31. Denoya P, Canedo J, Berho M, et al. Granulomas in Crohn's disease: does progression through the bowel layers affect presentation or predict recurrence? Colorectal Dis. 2011;13:1142-1147.
32. Heresbach D, Alexandre JL, Branger B, et al. Frequency and significance of granulomas in a cohort of incident cases of Crohn's disease. Gut. 2005; 54:215-222.
33. Leong RW, Lawrance IC, Chow DK, et al. Association of intestinal granulomas with smoking, phenotype, and serology in Chinese patients with Crohn's disease. Am J Gastroenterol. 2006;101:1024-1029.
34. Van Kruiningen HJ, Colombel JF. The forgotten role of lymphangitis in Crohn's disease. Gut. 2008;57:1-4.
35. Sura R, Colombel JF, Van Kruiningen HJ. Lymphatics, tertiary lymphoid organs and the granulomas of Crohn's disease: an immunohistochemical study. Aliment Pharmacol Ther. 2011;33:930-939.
36. Rahier JF, De Beauce S, Dubuquoy L, et al. Increased lymphatic vessel density and lymphangiogenesis in inflammatory bowel disease. Aliment Pharmacol Ther. 2011;34:533-543.
37. Mooney EE, Walker J, Hourihane DO. Relation of granulomas to lymphatic vessels in Crohn's disease. J Clin Pathol. 1995;48:335-338.
38. Rahier JF, Dubuquoy L, Colombel JF, et al. Decreased lymphatic vessel density is associated with postoperative endoscopic recurrence in Crohn's disease. Inflamm Bowel Dis. 2013;19:2084-2090.
39. Kalima TV. Experimental lymphatic obstruction in the ileum. Ann Chir Gynaecol Fenn. 1970;59:187-201.
40. Kalima TV, Saloniemi H, Rahko T. Experimental regional enteritis in pigs. Scand J Gastroenterol. 1976;11:353-362.
41. Glass RE, Baker WN. Role of the granuloma in recurrent Crohn's disease. Gut. 1976;17:75-77.
42. Cook MG. The size and histological appearances of mesenteric lymph nodes in Crohn's disease. Gut. 1972;13:970-972.
43. Williams WJ. Histology of Crohn's Syndrome. Gut. 1964;5:510-516.
44. Cullen G, O'Toole A, Keegan D, et al. Long-Derm clinical results of ileocecal resection for Crohn's disease. Inflamm Bowel Dis. 2007;13: 1369-1373.
45. Homan WP, Gray GF Jr, Dineen F. Granulomas in Crohn's disease. Lancet. 1978;2:112.
46. Wolfson DM, Sachar DB, Cohen A, et al. Granulomas do not affect postoperative recurrence rates in Crohn's disease. Gastroenterology. 1982;83:405-409.
47. Anseline PF, Wlodarczyk J, Murugasu R. Presence of granulomas is associated with recurrence after surgery for Crohn's disease: experience of a surgical unit. Br J Surg. 1997;84:78-82.
48. Bressenot A, Peyrin-Biroulet L. Histologic features predicting postoperative Crohn's disease recurrence. Inflamm Bowel Dis. 2015;21:468-475.
49. Willcox HN. Immunology, immunopathology and immunity. Immunol Today. 1988;9:183-184.
50. Alexander JS, Ganta VC, Jordan PA, et al. Gastrointestinal lymphatics in health and disease. Pathophysiology. 2010;17:315-335.
51. Deitch EA. Gut lymph and lymphatics: a source of factors leading to organ injury and dysfunction. Ann N Y Acad Sci. 2010;1207(suppl 1): E103-E111.
52. Alexander JS, Chaitanya GV, Grisham MB, et al. Emerging roles of lymphatics in inflammatory bowel disease. Ann N Y Acad Sci. 2010; 1207(suppl 1):E75-E85.
53. Heatley RV, Bolton PM, Hughes LE, et al. Mesenteric lymphatic obstruction in Crohn's disease. Digestion. 1980;20:307-313.
54. Kovi J, Duong HD, Hoang CT. Ultrastructure of intestinal lymphatics in Crohn's disease. Am J Clin Pathol. 1981;76:385-394.
55. Von Der Weid PY, Rehal S. Lymphatic pump function in the inflamed gut. Ann N Y Acad Sci. 2010;1207(suppl 1):E69-E74.
56. Crohn BB, Ginzburg L, Oppenheimer GD. Regional ileitis: a pathologic and clinical entity. 1932. Mt Sinai J Med. 2000;67:263-268.
57. Crohn BB, Ginzburg L, Oppenheimer GD. Regional ileitis; a pathologic and clinical entity. Am J Med. 1952;13:583-590.
58. Chan AK, Vergnolle N, Hollenberg MD, et al. Proteinase-Activated receptor 2 activation modulates guinea-pig mesenteric lymphatic vessel pacemaker potential and contractile activity. J Physiol. 2004;560:563-576.
59. Drake RE, Teague RA, Gabel JC. Lymphatic drainage reduces intestinal edema and fluid loss. Lymphology. 1998;31:68-73.
60. Fogt F, Pascha TL, Zhang PJ, et al. Proliferation of D2-40-expressing intestinal lymphatic vessels in the lamina propria in inflammatory bowel disease. Int J Mol Med. 2004;13:211-214.
61. Pedica F, Ligorio C, Tonelli P, et al. Lymphangiogenesis in Crohn's disease: an immunohistochemical study using monoclonal antibody D2-40. Virchows Arch. 2008;452:57-63.
62. Guo R, Zhou Q, Proulx ST, et al. Inhibition of lymphangiogenesis and lymphatic drainage via vascular endothelial growth factor receptor 3 blockade increases the severity of inflammation in a mouse model of chronic inflammatory arthritis. Arthritis Rheum. 2009;60: 2666-2676.